Pfizer (PFE) in Global Blood Therapeutics (GBT) Takeover Talks
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq ends down as chipmakers fall and bank earnings roll in
- Oil prices settle mixed, focus on US-Russia diesel deal, Saudi Yemen attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
GBT Announces New Employment Inducement Grants
August 4, 2022 4:05 PM EDTSOUTH SAN FRANCISCO, Calif., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc.(GBT) (NASDAQ: GBT) today announced that on August 1, 2022, the compensation committee of GBTs board of directors granted 10 new employees restricted stock units for an aggregate of 30,450 shares of the companys common stock. These awards were made under GBTs Amended and Restated 2017 Inducement Equity Plan (the Plan).Â
The above-described awards were... More



